Finance

Lists
Why is 000227 up 3,23%?
Dive Deeper
000227:KRX
Yuyu Pharma Pref Shs
7 990,00 KRW
+3,23%
(+250,00) 1D
19 ოქტ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000227...
Open
8 000 KRW
High
8 000 KRW
Low
7 720 KRW
Mkt. cap
70,90 მლრდ.
Avg. vol.
1,25 ათ.
Volume
208,00
Dividend
1,44%
Quarterly dividend
29 KRW
Ex-dividend date
27 დეკ. 2024
P/E ratio
11,93
52-wk high
12 400 KRW
52-wk low
5 810 KRW
EPS
669 KRW
Shares outstanding
322,96 ათ.
No. of employees
243
Open
8 000 KRW
High
8 000 KRW
Low
7 720 KRW
Mkt. cap
70,90 მლრდ.
Avg. vol.
1,25 ათ.
Volume
208,00
Dividend
1,44%
Quarterly dividend
29 KRW
Ex-dividend date
27 დეკ. 2024
P/E ratio
11,93
52-wk high
12 400 KRW
52-wk low
5 810 KRW
EPS
669 KRW
Shares outstanding
322,96 ათ.
No. of employees
243
News stories
From web sources and news partners
About Yuyu Pharma Pref Shs
CEO-
Employees243
Founded1941
Headquarters-
SectorPharmaceutical industry
Websiteyuyu.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
37,79 მლრდ.
34,34 მლრდ.
35,54 მლრდ.
36,70 მლრდ.
Cost of goods sold
23,00 მლრდ.
22,54 მლრდ.
21,04 მლრდ.
22,11 მლრდ.
Cost of revenue
23,00 მლრდ.
22,54 მლრდ.
21,04 მლრდ.
22,11 მლრდ.
Research and development expenses
914,90 მლნ.
1,15 მლრდ.
703,42 მლნ.
781,89 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,71 მლრდ.
10,17 მლრდ.
8,95 მლრდ.
9,33 მლრდ.
Operating expense
9,81 მლრდ.
11,93 მლრდ.
10,19 მლრდ.
10,59 მლრდ.
Total operating expenses
32,81 მლრდ.
34,47 მლრდ.
31,24 მლრდ.
32,69 მლრდ.
Operating income
4,99 მლრდ.
-129,07 მლნ.
4,30 მლრდ.
4,00 მლრდ.
Other non operating income
56,65 მლნ.
-1,13 მლრდ.
863,61 მლნ.
-184,40 მლნ.
EBT including unusual items
4,82 მლრდ.
202,03 მლნ.
3,97 მლრდ.
4,13 მლრდ.
EBT excluding unusual items
4,77 მლრდ.
-1,11 მლრდ.
4,99 მლრდ.
3,68 მლრდ.
Income tax expense
504,29 მლნ.
-1,00 მლრდ.
620,45 მლნ.
574,52 მლნ.
Effective tax rate
10,46%
-496,97%
15,62%
13,91%
Other operating expenses
18,27 მლნ.
76,24 მლნ.
40,94 მლნ.
36,86 მლნ.
Net income
3,98 მლრდ.
1,39 მლრდ.
3,49 მლრდ.
3,65 მლრდ.
Net profit margin
10,52%
4,03%
9,82%
9,95%
Earnings per share
-
-
-
-
Interest and investment income
136,07 მლნ.
529,96 მლნ.
286,44 მლნ.
226,76 მლნ.
Interest expense
-540,35 მლნ.
-547,07 მლნ.
-474,32 მლნ.
-436,45 მლნ.
Net interest expenses
-404,28 მლნ.
-17,11 მლნ.
-187,88 მლნ.
-209,69 მლნ.
Depreciation and amortization charges
320,96 მლნ.
403,34 მლნ.
334,87 მლნ.
409,27 მლნ.
EBITDA
6,34 მლრდ.
1,33 მლრდ.
5,68 მლრდ.
5,46 მლრდ.
Gain or loss from assets sale
-13,34 მლნ.
-
-499,00 ათ.
-3,19 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები